Assura Plc (LON:AGR – Get Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 48.45 and traded as high as GBX 48.50. Assura shares last traded at GBX 47.48, with a volume of 288,991 shares trading hands.
Analysts Set New Price Targets
AGR has been the topic of a number of analyst reports. Peel Hunt reiterated a “buy” rating and issued a GBX 60 target price on shares of Assura in a research report on Tuesday, September 30th. Shore Capital reiterated a “hold” rating on shares of Assura in a report on Wednesday, October 1st. One equities research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, Assura presently has an average rating of “Moderate Buy” and a consensus price target of GBX 60.
Read Our Latest Report on Assura
Assura Price Performance
About Assura
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.
Featured Stories
- Five stocks we like better than Assura
- Best Stocks Under $10.00
- The Trade Desk: After a 70% Plunge, This Could Be The Time to Buy
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Tap Into 2026 AI Infrastructure Gains With This High-Growth ETF
- 5 discounted opportunities for dividend growth investors
- Strong Quarter, Weak Reaction: Why GitLab Shares Dropped
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.
